Cargando…
Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America
BACKGROUND: Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation antihistamines as the cornerstone in therapy for chronic urticaria (C...
Autores principales: | Cherrez-Ojeda, Ivan, Maurer, Marcus, Bernstein, Jonathan A., Vanegas, Emanuel, Felix, Miguel, Ramon, German D., Ensina, Luis Felipe, Larco Sousa, José Ignacio, Matos Benavides, Edgar Emilio, Cardona Villa, R., Latour Staffeld, P., Morfin-Maciel, Blanca María, Mori, Jose, Wilches C, Paul, Mata, Valeria L., Cherrez, Annia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439401/ https://www.ncbi.nlm.nih.gov/pubmed/30937137 http://dx.doi.org/10.1016/j.waojou.2019.100011 |
Ejemplares similares
-
Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016) -
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2018) -
“Chronic urticaria and obstructive sleep apnea: Is there a significant association?”()
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2021) -
Urticaria as initial finding of a patient with carcinoid tumor
por: Cherrez Ojeda, Ivan, et al.
Publicado: (2015) -
Information and communication technology use in asthmatic patients: a cross-sectional study in Latin America
por: Calderón, Juan, et al.
Publicado: (2017)